Antiretroviral therapy coverage for PMTCT in Tunisia
Tunisia: Antiretroviral therapy coverage for PMTCT was 32.0% in 2024. ◆ Volatile
Antiretroviral therapy coverage for PMTCT in Tunisia, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.
Analysis
In 2024, antiretroviral therapy coverage for pmtct in Tunisia stood at 32.0%.
Compared with earlier readings it is up 33.3% on the previous year and up 10.3% over ten years.
Over the whole period, antiretroviral therapy coverage for pmtct in Tunisia peaked at 46.0% in 2022 and was at its lowest, 0.0%, in 2000.
Tunisia ranks 75th of 84 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage for PMTCT in Tunisia, year by year
| Year | % of pregnant women living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 3.0% | — |
| 2003 | 4.0% | +33.3% |
| 2004 | 2.0% | -50.0% |
| 2005 | 0.0% | -100.0% |
| 2006 | 0.0% | — |
| 2007 | 2.0% | — |
| 2008 | 3.0% | +50.0% |
| 2009 | 3.0% | +0.0% |
| 2010 | 10.0% | +233.3% |
| 2011 | 11.0% | +10.0% |
| 2012 | 11.0% | +0.0% |
| 2013 | 14.0% | +27.3% |
| 2014 | 29.0% | +107.1% |
| 2015 | 19.0% | -34.5% |
| 2016 | 14.0% | -26.3% |
| 2017 | 13.0% | -7.1% |
| 2018 | 14.0% | +7.7% |
| 2019 | 20.0% | +42.9% |
| 2020 | 32.0% | +60.0% |
| 2021 | 38.0% | +18.8% |
| 2022 | 46.0% | +21.1% |
| 2023 | 24.0% | -47.8% |
| 2024 | 32.0% | +33.3% |
Tunisia compared with similar countries
- Tunisia's 32.0% is below the median for lower middle income countries, which is 83.5%, 38% of the median. (32 countries reporting)
- Tunisia's 32.0% is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 32.0%, 1.0× the median. (9 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 1.7% | 0.0% | 4.0% | 10 |
| 2010s | 15.5% | 10.0% | 29.0% | 10 |
| 2020s | 34.4% | 24.0% | 46.0% | 5 |
Countries ranked near Tunisia
- 73 Mauritania 39.0% compare
- 74 Djibouti 38.0% compare
- 75 Democratic Republic of Congo 32.0% compare
- 77 Madagascar 30.0% compare
- 78 Papua New Guinea 28.0% compare
More health data for Tunisia
- Un projection of annual infant deaths, annual growth rate -1.68 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.2883 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,287 deaths per 1,000 people (2090)
- Number of infants who die before age 1 117 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -3.64 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.033 units per person (2025)
- Population ages 00-04, male, annual growth rate -3.77 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage for pmtct in Tunisia?
- Antiretroviral therapy coverage for pmtct in Tunisia was 32.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage for pmtct recorded in Tunisia?
- The highest recorded value was 46.0% in 2022.
- What is the lowest antiretroviral therapy coverage for pmtct recorded in Tunisia?
- The lowest recorded value was 0.0% in 2000.
- How does Tunisia rank for antiretroviral therapy coverage for pmtct?
- Tunisia ranks 75th out of 84 countries with data for 2024.
- Is antiretroviral therapy coverage for pmtct rising or falling in Tunisia?
- Over the last ten years it is up 10.3%. The long-run trend across the full record is volatile.
- Where does this Tunisia data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).